Our Leadership Team

Executive Team
Board of Directors

Gerald F. Joyce, M.D. Ph.D., — Gerald F. Joyce, M.D. Ph.D.,

Institute Director

Melissa Ashlock, M.D., — Melissa Ashlock, M.D.,

Head of Translational Research

Peter McNamara, Ph.D., — Peter McNamara, Ph.D.,

Executive Director of Biotherapeutics and Biotechnology

Shelly Meeusen, Ph.D., — Shelly Meeusen, Ph.D.,

Executive Director of General Medical Biology

Shifeng Pan, Ph.D., — Shifeng Pan, Ph.D.,

Executive Director of Discovery Chemistry

Julie McCarthy — Julie McCarthy

General Counsel and Vice President of Legal

Timothy Swaller

Head of Operations

Michael Mastracci, M.B.A. — Michael Mastracci, M.B.A.

Executive Director of Human Resources

I-An Suen — I-An Suen

CFA, Director of Finance

Dr. Jay Bradner, Chairman of GNF Board

President, NIBR

Ms. Revathi Rammohan

Chief Financial Officer, NIBR

Dr. Jeffrey Engelman

Global Head Oncology Drug Discovery, NIBR

Dr. Joerg Reinhardt

Chairman of NVS Board

John Tsai, M.D.

Global Head Drug Development and Chief Medical Officer, Novartis

Stuart L. Schreiber, Ph.D.

Harvard University, Broad Institute